[Treatment of lung cancer with Endoxan, with reference to the effect of massive intermittent administration].
D000368:Aged; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D003520:Cyclophosphamide